Cervical cancer (CC) is the fourth most common malignancy and cancer-related mortality cause in women worldwide. A significant portion of these patients are diagnosed as locally advanced cervical cancer (LACC), thus requiring combined therapies. We investigate the role of the lipid signal derived from 1H magnetic resonance (MR)-spectroscopy in assessing response to neoadjuvant chemotherapy of LACC.
This abstract and the presentation materials are available to members only; a login is required.